SHEPHERD WEALTH MANAGEMENT Ltd LIABILITY Co acquired a new position in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) during the fourth quarter, according to its most recent 13F filing with the SEC. The firm acquired 1,766 shares of the biotechnology company's stock, valued at approximately $1,050,000. Axon Enterprise accounts for 1.0% of SHEPHERD WEALTH MANAGEMENT Ltd LIABILITY Co's investment portfolio, making the stock its 24th biggest holding.
Several other hedge funds and other institutional investors have also modified their holdings of the company. Public Sector Pension Investment Board lifted its position in Axon Enterprise by 19.2% during the third quarter. Public Sector Pension Investment Board now owns 3,104 shares of the biotechnology company's stock valued at $1,240,000 after buying an additional 500 shares in the last quarter. CIBC Asset Management Inc grew its stake in shares of Axon Enterprise by 9.2% in the third quarter. CIBC Asset Management Inc now owns 10,578 shares of the biotechnology company's stock valued at $4,227,000 after buying an additional 895 shares in the last quarter. Axxcess Wealth Management LLC acquired a new position in Axon Enterprise during the 3rd quarter worth approximately $814,000. Soros Capital Management LLC purchased a new position in Axon Enterprise in the 3rd quarter worth approximately $630,000. Finally, Friedenthal Financial grew its position in Axon Enterprise by 961.7% in the fourth quarter. Friedenthal Financial now owns 1,359 shares of the biotechnology company's stock valued at $808,000 after acquiring an additional 1,231 shares in the last quarter. 79.08% of the stock is owned by institutional investors and hedge funds.
Axon Enterprise Price Performance
Shares of NASDAQ AXON opened at $526.64 on Wednesday. Axon Enterprise, Inc. has a 1-year low of $273.52 and a 1-year high of $715.99. The firm has a market capitalization of $40.35 billion, a PE ratio of 136.08, a P/E/G ratio of 5.17 and a beta of 1.12. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The business's fifty day moving average price is $596.28 and its two-hundred day moving average price is $532.72.
Wall Street Analyst Weigh In
A number of equities analysts have weighed in on AXON shares. Robert W. Baird upped their price objective on shares of Axon Enterprise from $600.00 to $800.00 and gave the company an "outperform" rating in a research report on Friday, December 6th. Morgan Stanley raised Axon Enterprise from an "equal weight" rating to an "overweight" rating and increased their price target for the company from $500.00 to $700.00 in a report on Tuesday, December 3rd. Craig Hallum lowered Axon Enterprise from a "buy" rating to a "cautious" rating in a research report on Monday. The Goldman Sachs Group raised their price target on shares of Axon Enterprise from $500.00 to $700.00 and gave the stock a "buy" rating in a research report on Monday, January 27th. Finally, TD Cowen started coverage on shares of Axon Enterprise in a research note on Wednesday, January 8th. They issued a "buy" rating and a $700.00 price target for the company. One analyst has rated the stock with a sell rating, three have issued a hold rating and twelve have issued a buy rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $587.38.
View Our Latest Analysis on Axon Enterprise
Insider Activity
In other Axon Enterprise news, Director Michael Garnreiter sold 1,000 shares of the business's stock in a transaction on Monday, December 16th. The stock was sold at an average price of $639.69, for a total transaction of $639,690.00. Following the completion of the transaction, the director now owns 24,259 shares in the company, valued at approximately $15,518,239.71. The trade was a 3.96 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Jeffrey C. Kunins sold 1,370 shares of the firm's stock in a transaction on Tuesday, December 17th. The shares were sold at an average price of $639.14, for a total value of $875,621.80. Following the transaction, the insider now directly owns 125,950 shares in the company, valued at $80,499,683. This trade represents a 1.08 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 5,146 shares of company stock valued at $3,262,847. Insiders own 6.10% of the company's stock.
About Axon Enterprise
(
Free Report)
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Axon Enterprise, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.
While Axon Enterprise currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.